Chronic kidney disease stage 5D
Conditions
Interventions
Kindary 3E, Carbostar P
Sponsors
Shonan Fujisawa Tokushukai Hospital
Shonankamakura General Hospital Shonanatsugi Hospital Hayama Heart Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Patients on hemodialysis 2)Being on hemodialysis for more than 12 weeks 3)Patients on hemodialysis with Kindary 3E 4)Aged between 20 and 80 years, either sex 5)Patients who are able to provide informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with arrhythmia or inability to hold their breath 2) Pregnant or lactating patients 3) Patients with severe liver disease (Child-Pugh score: 10 or more points) 4)Patients with anemia due to active bleeding 5)Diabetes patients treated with insulin 6)History of hospitalization for treatment within 12 weeks 7)Fever, or elevated CRP value (over the upper limit of institutional reference value) 8)Ejection fraction =<25%] 9) Patients after coronary artery angioplasty and stenting 10) Patients scheduled for coronary artery intervention or coronary artery bypass 11) Patients taking warfarin 12) Patients scheduled for parathyroidectomy or percutaneous ethanol injection therapy (PEIT). 13) Patients who received other study drugs or investigational drugs within 12 weeks 14) Patients judged unsuitable as research subjects
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Coronary artery calcification (6 months and 12 months after initiation) | — |
Countries
Japan
Contacts
Public ContactMachiko Oka
Shonan Fujisawa Tokushukai Hospital Division of Nephrology
Outcome results
None listed